Key result
Left ventricular hypertrophy in patients with uncomplicated essential hypertension was associated with elevated sVCAM-1 levels.
Why the study?
Does sVCAM-1 correlate with left ventricular mass in outpatients with uncomplicated essential hypertension?
Cross-Sectional (n=80)
Does sVCAM-1 correlate with left ventricular mass in outpatients with uncomplicated essential hypertension?
Answers are grounded in this paper and cite their sources.
Plasma sVCAM-1 levels are significantly elevated in and correlated with left ventricular hypertrophy in patients with uncomplicated essential hypertension, suggesting its utility as a biochemical marker for LV mass.
Plasma levels of soluble intercellular adhesion molecule-1 (sICAM-1), vascular adhesion molecule-1 (sVCAM-1), and E-selectin were measured in 80 outpatients with uncomplicated essential hypertension. Although the levels of E-selectin and sICAM-1 were similar between the patients with and without left ventricular (LV) hypertrophy, sVCAM-1 level was significantly elevated in the patients with LV hypertrophy (759.7+/-154.6 ng/mL nu 984.4+/-240.6 ng/mL, P < .0001). The LV mass normalized to body surface area or height were significantly correlated with sVCAM-1 (r=0.615, P < .0001 and r=0.571, P < .0001, respectively). These results indicate that a soluble adhesion molecule is correlated with LV mass in uncomplicated essential hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Yoko Kuroda (2001) conducted a cross-sectional in Uncomplicated essential hypertension (n=80). Left ventricular hypertrophy vs. Without left ventricular hypertrophy was evaluated on sVCAM-1 level (p=<0.0001). Left ventricular hypertrophy in patients with uncomplicated essential hypertension was associated with elevated sVCAM-1 levels.
Synapse has enriched 10 related papers. Consider them for comparative context: